- Tan, D. S. W., Kim, S. -., Ponce Aix, S., Sequist, L. V., Smit, E. F., Yang, J. C. H., Felip, E., . . . Kim, D. -. (2022). Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study. European Journal of Cancer, 172, 276-286. https://doi.org/10.1016/j.ejca.2022.05.023
Nazartinib for treatment-naive EGFR-mutant non−small cell lung cancer: Results of a phase 2, single-arm, open-label study
on 20 de setembre de 2022
with No hi ha comentaris
Deixa un comentari